Section one: Contracting authority
one.1) Name and addresses
Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency
10 South Colonnade
London
E14 4PU
Contact
UKHSA Commercial Operations
ProcurementNotices@ukhsa.gov.uk
Country
United Kingdom
Region code
UKI42 - Tower Hamlets
Internet address(es)
Main address
https://www.gov.uk/government/organisations/uk-health-security-agency
Buyer's address
https://www.gov.uk/government/organisations/uk-health-security-agency
one.3) Communication
Additional information can be obtained from the above-mentioned address
Electronic communication requires the use of tools and devices that are not generally available. Unrestricted and full direct access to these tools and devices is possible, free of charge, at
https://health-family.force.com/s/Welcome
one.4) Type of the contracting authority
Ministry or any other national or federal authority
one.5) Main activity
Health
Section two: Object
two.1) Scope of the procurement
two.1.1) Title
Clinical Evaluation
two.1.2) Main CPV code
- 73000000 - Research and development services and related consultancy services
two.1.3) Type of contract
Services
two.1.4) Short description
Delivery of evaluation studies relating to In Vitro Diagnostic devices (IVDs) or pathogen characterisation.
two.1.5) Estimated total value
Value excluding VAT: £2,500,000,000
two.1.6) Information about lots
This contract is divided into lots: No
two.2) Description
two.2.3) Place of performance
NUTS codes
- UK - United Kingdom
two.2.4) Description of the procurement
The UK Health Security Agency (UKHSA) wishes to inform the market of their intention to undertake preliminary market engagement in advance of any potential future procurement to source one or more Clinical Research Organisations (CRO) or equivalent organisations who have the capability and experience of operational delivery of evaluation studies relating to In Vitro Diagnostic devices (IVDs) or pathogen characterisation.
This will include amongst other things protocol development, re-kitting and distribution of diagnostic devices, study design, participant recruitment, data management and analysis, report writing and dissemination of findings to support the UK’s diagnostic testing and infectious disease surveillance capabilities.
This procurement will allow UKHSA to rapidly initiate evaluation studies in a range of settings including but not limited to primary care, NHS Trusts, organisations, and community.
It is UKHSA’s understanding that this activity is not widely carried out across the Public Sector, so UKHSA therefore wishes to explore the market, identify interest and potential solutions from suitably qualified suppliers and interested parties. The scope of our market engagement may be influenced by the responses we receive.
two.2.14) Additional information
Further information about the Meet the Buyer Event and Request for Information is available via this link
https://atamis-1928.my.salesforce.com/sfc/p/0O000000rwim/a/Sr0000004S5l/9fKXLoULf3Z5CEBPa8vkwJRRzE8XhFdgj__jvCJiaP0
Structure of procurement is yet to be determined this may be influenced by the Request for Information which in turn may influence the contract structure and value.
two.3) Estimated date of publication of contract notice
11 June 2024
Section four. Procedure
four.1) Description
four.1.8) Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement: Yes